Hassle-free access to a highly segmented, personalised list of investors
Looking for equity investment for your Life Sciences company? Start here and save yourself huge amounts of time, work and frustration.
Let us make this round of fundraising much, much easier for you.
Contacting the right investor is half the job
Ready to raise your seed round, series A or B? Then get ready to send your pitch deck to tons of info@someVC.com, get no reply, insist, visit every investment forum there is, and generally waste four months before you get any sort of feedback from a human being.
This is why we’re here: Capital Cell is a specialised Life Sciences investment company who partners with a wide range of Venture Capital Funds, Family Offices and specialised Business Angel networks, and we can get these first four months off your hands – as well as increase your chances of success.
Capital Cell provides hands-on, expert assessment on how ready for investment your company is, and offers specialist consulting to improve your chances of receiving investor attention.
We identify your potential investor pool based on your company’s maturity, sector, therapeutic target, round size, geographical compatibility and other parameters. Typically that would be between 30 and 150 extremely segmented investors.
We take care of contacting them and doing the necessary follow-up so we can serve you freshly baked meetings with interested parties. No time wasting, just investors who want to talk to you.
What can we do for you?
MEET OUR SERVICES
* Subject to approval
Segmented list of Investors : we present your company to a highly segmented list of professional investors
Deal circulation : emails, calls, visits and follow-ups .
Financial Review : financial analysis and review. Capital Cell’s approval on financial proposal .
Experts Review and Report : Project’s analysis through the BioExpert Network .
Modify Investment Proposal : Review and Modify content, texts, presentations, etc…
Review Round Strategy : includes 2H of consulting and new strategy proposal
We Manage for You all the Round : We negotiate for you with investors and take in charge the closing of the Round
Meet Some Partners
SV Life Sciences Managers manages life sciences investments. The investment team have a breadth of experience across both public and private investing. The majority of investments made are in the public markets, though private or venture capital investments.
Bloomium gives answers and guide those startups already created in their first years of life. Capable of identifying talent and transforming it into successful projects, Bloomium helps to reduce risks, and thus, to increase the chances of success.
Keytone Ventures leverages decades of collective expertise in venture capital to help entrepreneurs build industry-leading companies. Keytone Ventures is a venture capital firm investing in transformative ideas for the increasingly interconnected global economy.
Catapult Ventures is all about value creation through long term relationships – both with our portfolio companies and those who have invested in the funds we manage. Total of £130M under management.
NetScientific funds and develops companies that significantly improve the health and well-being of people with chronic diseases. Funding game-changing healthcare technology companies towards value inflection points and eventual exit including through a trade sale or public listing.
Seroba Life Sciences is a life sciences venture capital firm, focused on investing in breakthrough healthcare technologies that promise to improve lives and make a difference worldwide.
How we roll?
MEET THE TEAM
Capital Cell exists because of a clear market need for investors to have a simple portal on which to access life science deal flow, and for companies seeking funding to be properly represented to the right group of investors.
Capital Cell launched in December 2014 in Barcelona, Spain, after the founder Daniel Oliver realised that the generalist crowdfunding platform he had successfully established was not able to fully meet the needs of either the investors or companies seeking funding in the life science sector.
The BioExpert Network is our response to the fact that life sciences can be complex. We recognise that we don’t have all the answers, and have a deep respect for those who do. We are building a community around life science commercialisation that engages the wisdom of the crowd to move innovation forwards.
Since 2015, Capital Cell has become the leading non-institutional investor in life science in Spain. Capital Cell is now launching in Cambridge, UK, as the European hub of life science commercialisation.
We are in close relationship with
+300 Funds and VCs.
100% success fee !
Your success is our success !
Our Offices Around The World
MEET US FACE TO FACE
CAPITAL CELL SPAIN
Oficina 2D2, Plaça de Pau Vila, 1
The Hauser Forum 3
Charles Babbage Road,
Cambridge CB3 0GT UK
Business funding – Startup funding – small business funding – biotech funds – venture capital digital health – startup venture capital -best performing biotech funds – venture capital medical device – bio funds – VC biotech – VC digital health – VC life science – VC medical device – venture capital life science – venture capital medtech – science venture capital – biotech investment funds – life science capital – life sciences private equity – best biotech funds – biotech venture capital – biotech venture capital funding – biotechnology venture capital – venture capital biotech – top digital health investors